Author

Z. Taha

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Assay:proteomics· 1

Frequent Co-Authors

J.-S. Diallo· 2 shared A. Pelin· 1 shared A. Surendran· 1 shared B. Austin· 1 shared C. Matar· 1 shared C. S. Ilkow· 1 shared E. E. F. Brown· 1 shared G. Maznyi· 1 shared

Activity by Year

2021-2021 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

J.-S. Diallo

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

A small molecule drug screening identifies colistin sulfate as an enhancer of Natural Killer cell cytotoxicity.

S. Cortes-Kaplan, M. Hasim, S. Kaczmarek, Z. Taha, G. Maznyi, S. McComb, S.-H. Lee, J.-S. Diallo, M. Ardolino

The paper screens FDA-approved drugs to find a small molecule that enhances NK cell cytotoxicity against cancer cells.

bioRxiv · Aug 20, 2021 · PreprintImmunology

Characterization of Critical Determinants of ACE2-RBD Interaction

E. E. F. Brown, R. Rezaei, T. Jamieson, J. Dave, N. T. Martin, R. Singaravelu, M. J. F. Crupi, S. Boulton, S. Tucker, J. Duong, J. Poutou, A. Pelin, H. Yasavoli-Sharahi, Z. Taha, R. Arulanandam, , T. Azad

This study identifies critical amino acid residues in SARS-CoV-2 RBD and ACE2 that influence binding affinity and neutralization by antibodies and inhibitors.

bioRxiv · Jan 29, 2021 · PreprintMicrobiology